EVOME MEDICAL TECHNOLOGIES INC. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in CAD from 2020 to 2023

Taxonomy & unit
us-gaap: CAD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Evome Medical Technologies Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2020 to 2023.
  • Evome Medical Technologies Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending December 31, 2023 was -CA$15.7M, a 875% decline year-over-year.
  • Evome Medical Technologies Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending December 31, 2023 was -CA$15.1M, a 3.4% decline year-over-year.
  • Evome Medical Technologies Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was -CA$15.1M.
  • Evome Medical Technologies Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -CA$4.31M, a 39.1% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (CAD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (CAD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.